Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Forest Laboratories’ Lexapro is no longer the leading first-line agent of choice for the treatment of major depression. Lexapro may have lost its first-line...
Lexapro Loses First-Line Position For The Treatment Of Major Depression
Study Explains Association Between Depression And Cardiovascular Disease
Numerous studies have shown that depression is associated with an increased risk of heart disease, but exactly how has never been clear. Now, researchers at Rush University Medical Center have shown that depression is linked with the accumulation of visceral fat, the kind of fat packed between internal...
Female Cardiovascular Patients With Depression Incur Higher Health Care Costs
WHAT: Women with suspected coronary artery disease who suffer from depression have significantly higher health care costs than those who are not depressed, according to findings from the Women’s Ischemia Syndrome Evaluation (WISE), an ongoing, multicenter study funded by the National Institutes...
Anti-Social Behavior In Girls Predicts Adolescent Depression Seven Years Later
Past behavior is generally considered to be a good predictor of future behavior, but new research indicates that may not be the case in the development of depression, particularly among adolescent girls. University of Washington social scientists tracked first- and second-graders for seven years and...
Rexahn Pharmaceuticals, Inc. Initiates Clinical Trial Of Serdaxin(TM) To Treat Depression
Rexahn Pharmaceuticals, Inc. (NYSE Alternext US: RNN), a leader in development of innovative therapeutics for life-threatening and life-debilitating diseases, announced today that it has initiated a Phase IIa clinical trial for Serdaxin(TM), for the treatment of major depressive disorder (MDD). The Serdaxin...
Rexahn Pharmaceuticals, Inc. Initiates Clinical Trial Of SerdaxinTM To Treat Depression
Rexahn Pharmaceuticals, Inc. (NYSE Alternext US: RNN), a leader in development of innovative therapeutics for life-threatening and life-debilitating diseases, announced today that it has initiated a Phase IIa clinical trial for SerdaxinTM, for the treatment of major depressive disorder (MDD). The Serdaxin...
Possible Link Between Teen Smoking And Adult Depression
Teenagers who smoke could be setting themselves up for depression later in life, according to a groundbreaking new Florida State University study. Psychology Professor Carlos Bolanos and a team of researchers found that nicotine given to adolescent rats induced a depression-like state characterized by...
Internet Program Helps Prevent Depression In Teens
An Internet program helps to reduce depressive symptoms and prevent episodes of clinical depression in adolescent patients at risk, reports a study in the February issue of the Journal of Developmental & Behavioral Pediatrics. The journal is published by Lippincott Williams & Wilkins, a part...
Well-Developed Community Mental-Health Services Are Associated With Lower Suicide Rates
Well-developed community mental-health services are associated with lower suicide rates than are services oriented towards inpatient treatment provision in hospitals. Thus population mental health can be improved by the use of multi-faceted, community-based, specialised mental-health services. These...
Prozac: Not Just For Depression
Prozac is regularly prescribed to ease the emotional pain of patients who are being treated for cancer. But can this common anti-depressant help to fight cancer itself? Dr. Dan Peer of the Department of Cell Research and Immunology at Tel Aviv University is proving that it can. A study he and his colleagues...